Evogene reports Q2 revenue slip; says herbicide, insect control milestones are indicative of progress on innovative tech
In Israel, Evogene reported Q2 2015 revenues from research and development payments for the six months ended June 30, 2015 were $5.3 million, compared to $7.5 million for the same period in 2014. Revenues from research and development payments for Q2 2015 were $2.6 million, compared to $3.8 million for the same period in 2014. […]









